Symptomtext
Fever (100.1 F); Nausea; Vaccine location: left leg; This is a spontaneous report received from a contactable reporter (consumer or other non HCP). A 7-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in leg left, administration date 02Dec2021 at 15:00 (Lot number: 5618) at the age of 7 years as dose 2 (tris), single for COVID-19 immunisation. Relevant medical history included: "None" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Amoxicillin, reaction(s): "Drug allergy", notes: Known allergies: Amoxicillin. Vaccination history included: Bnt162b2 (DOSE 1 (TRIS), SINGLE , Lot number: FK5127, Route of administration: intramuscular), administration date: 09Nov2021, when the patient was 7 years old, for COVID-19 immunisation. The following information was reported: PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset 02Dec2021 at 15:00, outcome "unknown", described as "Vaccine location: left leg"; PYREXIA (non-serious) with onset 03Dec2021, outcome "not recovered", described as "Fever (100.1 F)"; NAUSEA (non-serious) with onset 03Dec2021, outcome "not recovered", described as "Nausea". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia and nausea. Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.